alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
SALIVA DIAGNOSTIC SYSTEMS, INC.
                        COMPUTATION OF EARNINGS PER SHARE
                                   (UNAUDITED)

                                            Three months ended March 31,
                                              2001              2000
                                              ----              ----
Basic earnings:
Net (loss)                              $     (227,689)    $      (240,630)
                                        --------------     ----------------
Shares:
Weighted common shares outstanding          28,757,864          16,227,710
                                        --------------     ---------------
Basic net  (loss) per share             $        (0.01)    $          (0.01)
                                        ==============     ================
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<MULTIPLIER> 1,000
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-START>                             JUL-01-1995
<PERIOD-END>                               JUN-30-1996
<CASH>                                           2,460
<SECURITIES>                                         0
<RECEIVABLES>                                   39,445
<ALLOWANCES>                                     2,219
<INVENTORY>                                     59,883
<CURRENT-ASSETS>                               103,665
<PP&E>                                          36,325
<DEPRECIATION>                                  18,597
<TOTAL-ASSETS>                                 142,637
<CURRENT-LIABILITIES>                           52,949
<BONDS>                                        112,336
<COMMON>                                           118
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    (43,136)
<TOTAL-LIABILITY-AND-EQUITY>                   142,637
<SALES>                                        235,067
<TOTAL-REVENUES>                               235,067
<CGS>                                          160,556
<TOTAL-COSTS>                                   70,628
<OTHER-EXPENSES>                                19,507
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              24,264
<INCOME-PRETAX>                                 26,029
<INCOME-TAX>                                     2,395
<INCOME-CONTINUING>                             23,634
<DISCONTINUED>                                  11,000
<EXTRAORDINARY>                                (6,251)
<CHANGES>                                      (8,213)
<NET-INCOME>                                    19,195
<EPS-PRIMARY>                                    $1.63
<EPS-DILUTED>                                    $1.41
        

</TABLE>
Capital Income Builder, Inc.
          333 South Hope Street, Los Angeles, California  90071
                      Telephone: (213) 486-9200
 
                                           January 5, 1999
 
Document Control
U.S. Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C.  20549
 
Re:  Capital Income Builder, Inc. 
     File Nos. 811-5085 and 33-12967
                                                                             
Gentlemen:
 
      Pursuant to Rule 497(j), I hereby certify that no changes have been made
to the form of prospectus and Statement of Additional Information since the
electronic filing on 12/29/98 of Registrant's Post-Effective Amendment No. 14
under The Securities Act of 1933 and Amendment No. 16 under The Investment
Company Act of 1940.
 
 
                                           Sincerely,
                                           /s/Vincent P. Corti
                                           Vincent P. Corti
                                           Secretary
 
cc: Mr. Frank Dalton
    Mr. Bric Barrientos 
    (Division of Investment Management)
[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Page 37841]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17120]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[S-75-2017]


Approval of Subzone Status; Universal Metal Products, Inc.; 
Pharr, Texas

    On May 10, 2017, the Executive Secretary of the Foreign-Trade Zones 
(FTZ) Board docketed an application submitted by McAllen Foreign Trade 
Zone, Inc., grantee of FTZ 12, requesting subzone status subject to the 
existing activation limit of FTZ 12, on behalf of Universal Metal 
Products, Inc., in Pharr, Texas.
    The application was processed in accordance with the FTZ Act and 
Regulations, including notice in the Federal Register inviting public 
comment (82 FR 25240, June 1, 2017). The FTZ staff examiner reviewed 
the application and determined that it meets the criteria for approval. 
Pursuant to the authority delegated to the FTZ Board Executive 
Secretary (15 CFR Sec. 400.36(f)), the application to establish Subzone 
12B was approved on July 14, 2017, subject to the FTZ Act and the 
Board's regulations, including Section 400.13, and further subject to 
FTZ 12's 873.5-acre activation limit.

    Dated: August 8, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017-17120 Filed 8-11-17; 8:45 am]
 BILLING CODE 3510-DS-P
# Continuation of the National Emergency With Respect to Export Control Regulations

                        On August 17, 2001, the President issued Executive Order 13222 pursuant to the International Emergency Economic Powers Act (50 U.S.C. 1701*et seq.*). In that order, the President declared a national emergency with respect to the unusual and extraordinary threat to the national security, foreign policy, and economy of the United States related to the expiration of the Export Administration Act of 1979, as amended (50 U.S.C. 4601*et seq.*). Because the Congress has not renewed the Export Administration Act, the national emergency declared on August 17, 2001, must continue in effect beyond August 17, 2017. Therefore, in accordance with section 202(d) of the National Emergencies Act (50 U.S.C. 1622(d)), I am continuing for 1 year the national emergency declared in Executive Order 13222, as amended by Executive Order 13637 of March 8, 2013.                    

                        This notice shall be published in the                         *Federal Register*                         and transmitted to the Congress.                    

[FR Doc. 2017-17486

Billing code 3295-F7-P
Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement Nos.333-56918 and 333-104787 on Form S-3, and 333-63101, 333-71990, 333-71992,333-81134 and 333-93193 on Form S-8 of our report relating to theconsolidated financial statements and financial statement schedules ofWPS Resources Corporation and subsidiaries dated March 9, 2005 (whichreport expresses an unqualified opinion and includes an explanatory paragraphrelating to the adoption of new accounting principles) and of our report datedMarch 9, 2005 relating to management's report of the effectiveness of internalcontrol over financial reporting, appearing in this Annual Report on Form 10-Kof WPS Resources Corporation for the year ended December 31, 2004.

/s/ Deloitte & Touche LLP

Milwaukee, WisconsinMarch 9, 2005
No. 1275.

#### Robinson *v.*Illinois.

June 10, 1946.

Petition for writ of certiorari to the Supreme Court of Illinois denied.
Exhibit 99.1

AstroPower, Inc.  CERTIFICATION PURSUANT TO  18 U.S.C SECTION 1350,  AS ADOPTED PURSUANT TO



In connection with the Quarterly Report if AstroPower, Inc. (the "Company) on Form 10-Q for the period ending September 30, 2002
as filed with the Securities and Exchange Commission on the date hereof (the "report"), I, Allen M. Barnett, President and Chief Executive Officer of the company, certify, pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:



|Date: November 13, 2002 |  | By: | /s/ALLEN M. BARNETTAllen M. Barnett
President and Chief Executive Officer
|----------------------- |  | --- | -------------------------------------------------------------------------

---

QuickLinks
**Exhibit 32.2**

 

**Certificationof Executive Vice President and Chief Financial Officer**

**Pursuantto Section 906 of the Sarbanes-Oxley Act of 2002**

 

The undersigned officerof Watson Pharmaceuticals, Inc. (the “Company”), hereby certifies, to suchofficer’s knowledge, that:

 

(i)                                     the accompanying Quarterly Report on Form 10-Qof the Company for the quarter ended March 31, 2005 (the “Report”) fullycomplies with the requirements of Section 13(a) or Section 15(d),as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(ii)                                  the information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

 
| Date:  May 9, 2005 |   | ** **                                               |
|------------------------------|--------|----------------------------------------------------------|
|                         | By:    | **/s/  Charles P. Slacik**                               |
|                         |   | Charles P.  Slacik                                       |
|                         |   | Executive Vice  President – Chief Financial Officer |
|                         |   | (Principal  Financial Officer)                           |

 

 

The foregoing certification is being furnished solelyto accompany the Report pursuant to 18 U.S.C. § 1350, and is not beingfiled for purposes of Section 18 of the Securities Exchange Act of 1934,as amended, and is not to be incorporated by reference into any filing of theCompany, whether made before or after the date hereof, regardless of anygeneral incorporation language in such filing.

 

----
##### 



EXHIBIT 31.2
 CFO CERTIFICATION
PURSUANT TO SECTION 302 OF THE
SARBANES  OXLEY ACT OF 2002
      a)
    
    designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;b)
    
    evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; andc)
    
    disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the registrants
most recent fiscal quarter (the registrants fourth fiscal quarter in the case
of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting;
and
  a)
    
    all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; andb)
    
    any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal
control over financial reporting.
  CINEMARK USA, INC.By:
    
    /s/ Robert Copple

Robert Copple
Chief Financial Officer
Exhibit 23.1

 

 

INDEPENDENT AUDITORS' CONSENT

 

We consent to the incorporation by reference in Registration Statement No. 333-107694 of Wisconsin Gas Company on Form S-3 of our report dated March 29, 2004, relating to the financial statements of Wisconsin Gas Company as of and for the years ended December 31, 2003 and 2002 (which report expresses an unqualified opinion and includes explanatory paragraphs relating to (i) the adoption of a new accounting principle, (ii) the restatement of the 2002 financial statements and (iii) the application of procedures relating to certain disclosures related to the 2001 financial statements that were audited by other auditors who have ceased operations and for which we have expressed no opinion or other form of assurance other than with respect to such disclosures), appearing in this Annual Report on Form 10-K of Wisconsin Gas Company for the year ended December 31, 2003.

 

 

/s/ DELOITTE & TOUCHE LLP
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 05-7868
GEORGE L. SPENCER, Plaintiff - Appellant, versus PAUL WILLIAMS, Dr.; VICKI PHIPPS, RNCB/DON; F. TAYLOR, Grievance Coordinator; R. MULLINS, Grievance Coordinator; TRACY S. RAY, Warden, Defendants - Appellees. Appeal from the United States District Court for the Western District of Virginia, at Roanoke. James C. Turk, Senior District Judge. (CA-05-627-7) Submitted: February 23, 2006 Decided: March 6, 2006 Before WIDENER, NIEMEYER, and KING, Circuit Judges. Affirmed by unpublished per curiam opinion. George L. Spencer, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: George L. Spencer appeals the district court’s order dismissing without prejudice pursuant to 28 U.S.C. § 1915A(b)(1) (2000), his action filed under 42 U.S.C. § 1983 (2000), for failure to state a claim and the court’s order denying his motion for reconsideration. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. See Spencer v. Williams , No. CA-05-627-7 (W.D. Va. Oct. 19, 2005; Nov. 2, 2005). We deny Spencer’s motion to appoint counsel and dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Dismissed and Memorandum Opinion filed August 28 , 2012.

In The 

## Fourteenth Court of Appeals

NO. 14

- 12

- 00666

- CR

ALVIN CHARLES DUNCAN , Appellant

V.

THE STATE OF TEXAS , Appellee

On Appeal from the 263rd District Court

Harris County, Texas Trial Court Cause No. 419955



### M E M O R A N D U M O P I N I O N

This is an attempted appeal from the denial of appellant's motion for judgment nunc pro tunc

. We dismiss the appeal.
Generally, an appellate court only has jurisdiction to consider an appeal by a
criminal defendant where there has been a final judgment of conviction. Workman v. State, 170 Tex. Crim. 621, 343 S.W.2d 446, 447 (1961) ; McKown v. State, 915 S.W.2d 160, 161 (Tex. App.

-- Fort Worth 1996, no pet.) . The exceptions include: (1) certain appeals while on deferred adjudication community supervision, Kirk v. State, 942 S.W.2d2

624, 625 (Tex. Crim. App. 1997) ; (2) appeals from the denial of a motion to reduce bond,
Tex. R. App. P. 31.1 ; McKown, 915 S.W.2d at 161; and (3) certain appeals from the
denial of habeas corpus relief, Wright v. State, 969 S.W.2d 588, 589 (Tex. App.

-- Dallas 1998, no pet.) ; McKown, 915 S.W.2d at 161

. The denial of a motion for a nunc pro tunc judgment is not an appealable order. See Sanchez v. State , 112 S.W.3d 311, 312 (Tex. App.

-- Corpus Christi 2003, no pet.);
Everett v. State
, 82 S.W.3d 735, 735 (Tex. App.

- - Waco 2002, pet dism'd

. ) Because this appeal does not fall within the exceptions to the general rule that appeal may be taken only from a final judgment of conviction, we have no jurisdiction. See Abbot v State , 271 S.W. 3d 694, 697 (Tex. Crim. App. 2008)

. Accordingly, the appeal is ordered dismissed.

PER CURIAM

Panel consists of Justices Frost, Christopher, and Jamison. Do Not Publish

— T ex. R. App. P. 47.2(b).
Exhibit 32

   Certification Required Under Section 906 of the Sarbanes-Oxley Act of 2002

     In  connection  with the filing of the  financial  statements of Ophthalmic
Imaging  Systems  ("Registrant")  for the  quarter  ended  March  31,  2004 (the
"Report"),   each  of  the  undersigned  hereby  certifies,  to  such  officer's
knowledge, that:


1.   The Report fully complies with the  requirements  of section 13(a) or 15(d)
     of the Securities Exchange Act of 1934, as amended, and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of Registrant.



                                                       /s/ Gil Allon
                                                       -------------------------
                                                       Gil Allon
                                                       Chief Executive Officer


                                                       /s/ Ariel Shenhar
                                                       -------------------------
                                                       Ariel Shenhar
                                                       Chief Financial Officer



                                       17
Exhibit 23.1
  CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  
 We hereby consent to the incorporation by reference in this Registration Statement on FormS-8of our reportdated September 22, 2010 relating to the consolidated financial statements, financial statement schedule, and the effectiveness of internal control over financial reporting, which appears in Vail Resorts, Inc.'s Annual Report on Form 10-K for the year ended July 31, 2010.
  
  /s/ PricewaterhouseCoopers LLP
  Denver, Colorado
  September 22, 2010
II 

114TH CONGRESS 

1ST SESSION S. 484 

To protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services 

under Federal health care programs and to ensure that comparative 

effectiveness research accounts for advancements in personalized medicine 

and differences in patient treatment response. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 12, 2015 

Mr. ROBERTS (for himself, Mr. BARRASSO, and Mr. PORTMAN) introduced the 

following bill; which was read twice and referred to the Committee on Finance 

A BILL 

To protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny 

or delay coverage of items or services under Federal 

health care programs and to ensure that comparative 

effectiveness research accounts for advancements in personalized medicine and differences in patient treatment 

response. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Preserving Access to 

5 Targeted, Individualized, and Effective New Treatments 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•S 484 IS

1 and Services (PATIENTS) Act of 2015’’ or the ‘‘PA2 TIENTS Act of 2015’’. 

3 SEC. 2. PROHIBITION ON CERTAIN USES OF DATA OB4 TAINED FROM COMPARATIVE EFFECTIVE5 NESS RESEARCH; ACCOUNTING FOR PERSON6 ALIZED MEDICINE AND DIFFERENCES IN PA7 TIENT TREATMENT RESPONSE. 

8 (a) IN GENERAL.—Notwithstanding any other provi9 sion of law, the Secretary of Health and Human Serv10 ices— 

11 (1) shall not use data obtained from the con12 duct of comparative effectiveness research, including 

13 such research that is conducted or supported using 

14 funds appropriated under the American Recovery 

15 and Reinvestment Act of 2009 (Public Law 111–5) 

16 or authorized or appropriated under the Patient 

17 Protection and Affordable Care Act (Public Law 

18 111–148), to deny or delay coverage of an item or 

19 service under a Federal health care program (as de20 fined in section 1128B(f) of the Social Security Act 

21 (42 U.S.C. 1320a–7b(f))); and 

22 (2) shall ensure that comparative effectiveness 

23 research conducted or supported by the Federal 

24 Government accounts for factors contributing to dif25 ferences in the treatment response and treatment 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•S 484 IS

1 preferences of patients, including patient-reported 

2 outcomes, genomics and personalized medicine, the 

3 unique needs of health disparity populations, and in4 direct patient benefits. 

5 (b) RULE OF CONSTRUCTION.—Nothing in this sec6 tion shall be construed as affecting the authority of the 

7 Commissioner of Food and Drugs under the Federal 

8 Food, Drug, and Cosmetic Act or the Public Health Serv9 ice Act. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
No. 1266.

#### Small *v.*Webster, Superintendent.

June 10, 1946.

Petitioner *pro se.*

Petition for writ of certiorari to the Court of Appeals of New York denied.

*874
      *Nathaniel L. Goldstein,*Attorney General of New York, and *Wendell P. Brown,*Solicitor General, for respondent.
IV 

108TH CONGRESS 

1ST SESSION H. RES. 101

Urging the President to present posthumously a Presidential Citizens Medal 

to Frederick Douglass in recognition of his achievements in civil rights 

and service to the nation. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 25, 2003

Mr. HASTINGS of Florida submitted the following resolution; which was 

referred to the Committee on Government Reform 

RESOLUTION

Urging the President to present posthumously a Presidential 

Citizens Medal to Frederick Douglass in recognition of 

his achievements in civil rights and service to the nation.

Whereas abolitionist, editor, orator, reformer, and civil rights 

activist Frederick Douglass was one of the most influential African-American leaders of the nineteenth century; 

Whereas the fourth of seven children born to a field hand in 

Talbot County, Maryland, Frederick Douglass escaped 

slavery with great adversity to become a forefather in 

civil and women’s rights; 

Whereas throughout his extraordinary life, Frederick Douglass gained international prominence for his lecturing and 

autobiographical writings, in which he detailed the callousness of slavery; 
2

•HRES 101 IH 

Whereas his notoriety was largely attributed to the founding 

of the North Star, a weekly newspaper that not only 

spoke against slavery and oppression but also served as 

a station on the Underground Railroad; 

Whereas Douglass’ achievements were also highlighted by a 

successful political career; and 

Whereas he served as an advisor to Presidents Abraham Lincoln and Andrew Johnson, was appointed as Assistant 

Secretary of the Commission of Inquiry to Santo Domingo by President Ulysses S. Grant, was appointed U.S. 

Marshal of the District of Columbia by President Rutherford B. Hayes, and was named Recorder of Deeds for the 

District of Columbia in 1881 by President James L. Garfield, all of which were firsts for African-Americans: Now, 

therefore, be it

1 Resolved, That the House of Representatives—

2 (1) recognizes and honors Frederick Douglass’ 

3 unwavering dedication to equality and civil rights; 

4 (2) acknowledges the profound contributions 

5 Frederick Douglass made to American history; 

6 (3) nominates Frederick Douglass to receive the 

7 Presidential Citizens Medal; and 

8 (4) urges the President to award a Presidential 

9 Citizens Medal in honor of Frederick Douglass.

Æ
No. 1201.

#### United States ex rel. Karpathiou *v.*Jordan, District Director of Immigration & Naturalization.

June 10, 1946.

*Harry G. Johnson*for.petitioner.

*Solicitor General McGrath, Robert S. Erdahl*and *Leon Ulman*for respondent.

Petition for writ of certiorari to the Circuit Court of Appeals for the Seventh Circuit denied.